MEDP
Medpace Holdings, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$656.87
−1.00%Forward multiples
Based on analyst estimates
- P/E forward
- 34.07x
- P/E 2026E
- 36.84x
- P/E 2027E
- 34.12x
- P/E 2028E
- 30.49x
- P/S forward
- 6.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- 35.78x
- PEG TTM
- 7.30x
- Price / book
- 31.41x
- Price / sales
- 6.47x
- Price / cash flow
- 25.41x
Enterprise value
- Enterprise value
- $17.8B
- EV / sales
- 6.28x
- EV / EBITDA
- 27.68x
- EV / EBIT
- 29.34x
- Market cap
- $18.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026